Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in

Sadako Motoyama1, Hajime Ito2, Masayoshi Sarai2

  • 1Department of Cardiology, Fujita Health University, Toyoake, Japan; Division of Cardiology, Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai, New York, New York.

Insights

Coronary computed tomography angiography (CTA) identified high-risk plaques (HRP) as predictors of acute coronary syndrome (ACS). Plaque progression on serial CTA also independently predicted ACS, highlighting its clinical significance.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Radiology

Background:

  • Coronary computed tomography angiography (CTA) identifies high-risk plaque (HRP) features like positive remodeling and low attenuation, predicting short-term acute coronary syndrome (ACS) risk.
  • Understanding mid-term ACS prediction based on CTA-verified plaque characteristics is crucial for patient management.

Purpose of the Study:

  • To evaluate the mid-term predictive value of CTA-verified plaque characteristics for acute coronary syndrome (ACS).
  • To assess the association between high-risk plaque (HRP), significant stenosis (SS), and plaque progression (PP) with mid-term ACS events.

Main Methods:

  • A cohort of 3,158 patients undergoing CTA had HRP and SS (≥70%) evaluated.
  • Serial CTA was performed in 449 patients to assess plaque progression (PP).
  • Mid-term outcomes, including fatal and nonfatal ACS, were recorded over a mean follow-up of 3.9 years.

Main Results:

  • ACS occurred in 2.8% of patients; incidence was higher in HRP+ (16.3%) and SS+ (5.5%) groups compared to HRP- (1.4%) and SS- (2.1%) groups.
  • While HRP+ lesions showed higher ACS rates, the absolute number of ACS events from HRP- lesions was similar to HRP+ lesions.
  • Plaque progression (PP) was an independent predictor of ACS, with significantly higher rates in PP+ patients (27% with HRP, 10% without HRP) versus PP- patients (0.3%).

Conclusions:

  • CTA-verified HRP is an independent predictor of mid-term ACS.
  • Despite HRP being a predictor, a substantial number of ACS events originated from non-HRP lesions.
  • Plaque progression detected by serial CTA independently predicts ACS, adding crucial prognostic information beyond initial plaque characterization.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
864
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
994
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
763
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
419